Lilly launches lower-price weight loss drug without injector pen - CNN
- Lilly launches lower-price weight loss drug without injector pen CNN
- Lilly releases Zepbound® (tirzepatide) single-dose vials, expanding supply and access for adults living with obesity Investors | Eli Lilly and Company
- Drug maker cutting prices for obesity, diabetes drug The Hill
- A Popular Weight Loss Drug Is Getting a Price Cut The New York Times